1. Home
  2. LGVN vs UPXI Comparison

LGVN vs UPXI Comparison

Compare LGVN & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • UPXI
  • Stock Information
  • Founded
  • LGVN 2014
  • UPXI 2018
  • Country
  • LGVN United States
  • UPXI United States
  • Employees
  • LGVN N/A
  • UPXI N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • UPXI Medicinal Chemicals and Botanical Products
  • Sector
  • LGVN Health Care
  • UPXI Health Care
  • Exchange
  • LGVN Nasdaq
  • UPXI Nasdaq
  • Market Cap
  • LGVN 7.8M
  • UPXI 7.5M
  • IPO Year
  • LGVN 2021
  • UPXI 2021
  • Fundamental
  • Price
  • LGVN $3.90
  • UPXI $0.42
  • Analyst Decision
  • LGVN Strong Buy
  • UPXI Hold
  • Analyst Count
  • LGVN 1
  • UPXI 1
  • Target Price
  • LGVN $12.00
  • UPXI $1.25
  • AVG Volume (30 Days)
  • LGVN 11.1M
  • UPXI 104.6K
  • Earning Date
  • LGVN 08-09-2024
  • UPXI 07-09-2024
  • Dividend Yield
  • LGVN N/A
  • UPXI N/A
  • EPS Growth
  • LGVN N/A
  • UPXI N/A
  • EPS
  • LGVN N/A
  • UPXI N/A
  • Revenue
  • LGVN $978,000.00
  • UPXI $81,433,807.00
  • Revenue This Year
  • LGVN $137.24
  • UPXI $18.98
  • Revenue Next Year
  • LGVN $50.77
  • UPXI $8.09
  • P/E Ratio
  • LGVN N/A
  • UPXI N/A
  • Revenue Growth
  • LGVN N/A
  • UPXI 16.95
  • 52 Week Low
  • LGVN $0.77
  • UPXI $0.34
  • 52 Week High
  • LGVN $36.50
  • UPXI $2.40
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 63.21
  • UPXI 47.99
  • Support Level
  • LGVN $3.36
  • UPXI $0.38
  • Resistance Level
  • LGVN $6.40
  • UPXI $0.45
  • Average True Range (ATR)
  • LGVN 0.63
  • UPXI 0.05
  • MACD
  • LGVN 0.18
  • UPXI 0.00
  • Stochastic Oscillator
  • LGVN 49.39
  • UPXI 50.31

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About UPXI Upexi Inc.

Upexi Inc is an innovator in aggregation, accelerating Amazon and eCommerce businesses by combining consumer data and vertical integration to scale brands in multiple industries, while lowering costs with a growing distribution network.

Share on Social Networks: